Buyouts of Indian pharmaceutical companies by multinational pharmaceutical companies: an issue of concern

Contract manufacturing, Foreign Direct Investment policy, drug regulatory reforms, reverse engineering of patented products, Trade-Related Intellectual Property agreement are a few factors behind the success story. Issue of concern is that the companies which were taken over by foreign companies are...

Full description

Saved in:
Bibliographic Details
Published inJournal of young pharmacists Vol. 3; no. 4; pp. 343 - 344
Main Authors Sreedhar, D, Janodia, Md, Ligade, Vs
Format Journal Article
LanguageEnglish
Published India Medknow Publications and Media Pvt. Ltd 01.10.2011
InPharm
Medknow Publications & Media Pvt Ltd
Subjects
Forecasts and trends
Generic drugs
Growth
Growth rate
Letter to the Editor
Mergers, acquisitions and divestments
Pharmaceutical industry
Regulatory reform
Reverse engineering
India
Online AccessGet full text

Cover

More Information
Summary:Contract manufacturing, Foreign Direct Investment policy, drug regulatory reforms, reverse engineering of patented products, Trade-Related Intellectual Property agreement are a few factors behind the success story. Issue of concern is that the companies which were taken over by foreign companies are major producers of cheaper generic versions of essential medicines and vaccines with extensive market reach in India and other developing countries.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0975-1483
0975-1505
DOI:10.4103/0975-1483.90250